[ad_1] Zusammenarbeit zur Kombination von Experience im App-Markt, globaler Gerätepräsenz und innovativer Technologie Stärkung der Partnerschaft nach der Gründung der Partnerschaft im Februar 2024 ONE Pack setzt die strategische globale Growth mit regionaler Anpassung und […]
Trending Stories
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combination as First-Line Therapy for Biliary Tract Tumors, Compared to Durvalumab
[ad_1] HONG KONG, Oct. 31, 2024 /PRNewswire/ — Akeso Biopharma (9926.HK) is pleased to announce the successful enrollment of the first patient in the AK112-309 trial, a randomized, controlled, multicenter Phase III registration study for […]
Generations of ‘temple caretakers,’ dedicated to relics preservation, embody China’s unwavering commitment to building a cultural powerhouse
[ad_1] BEIJING, Oct. 31, 2024 /PRNewswire/ — Wang Gaiying, 76, believes her connection to the Tiefo Temple goes beyond simply earning a living. Over the past decades, as a caretaker, she has meticulously kept this once […]
Prime Minister Fico’s visit reflects positive aspects of China-Europe relations: Global Times editorial
[ad_1] BEIJING, Oct. 31, 2024 /PRNewswire/ — On Thursday, Robert Fico, prime minister of the Slovak Republic, arrived in Beijing to start a six-day official visit to China. Before his departure, he stated that this is […]
ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
[ad_1] Efficacy signals observed will not achieve ESSA’s target product profile in patients with metastatic castration-resistant prostate cancer naïve to second-generation antiandrogens A futility analysis conducted as part of a protocol-specified interim review of the […]











